ILANIT 2020

Redistribution of chromatin binding of tumor suppressors drive transcriptional reprogramming in HRas-induced transformation

Ofir Hakim 1 Michal Schwartz 1 Avital Sarusi Portugez 1 Bracha Zukerman Attia 1 Miriam Tannenbaum 1 Olga Loza 1 Tommy Kaplan 2 Zaidoun Salah 3
1The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Israel
2School of Computer Science and Engineering, The Hebrew University of Jerusalem, Israel
3Al-Quds-Bard College for Arts and Sciences, Al-Quds University, Palestinian Territory

Gene transcription is substantially regulated by distant regulatory elements via combinatorial binding of transcription factors. It is more and more recognized that alterations in chromatin state and transcription factor binding in these distant regulatory elements may have key roles in cancer development. Here we focused on the first stages of oncogene induced carcinogenic transformation, and characterized the regulatory network underlying transcriptional reprogramming associated with this process. Using Hi-C data, we couple between differentially expressed genes and their differentially active regulatory elements and reveal two candidate transcription factors, p53 and CTCF, as major determinants of transcriptional reprogramming at early stages of HRas-induced transformation. Strikingly, the malignant transcriptional reprograming is promoted by redistribution of chromatin binding of these factors without major variation in their expression level. Our results demonstrate that alterations in the regulatory landscape have a major role in driving oncogene-induced transcriptional reprogramming.









Powered by Eventact EMS